RxDoctor Payments Data

James Barr, MD

Family Medicine · Dublin, OHNPI 1255370581

Payments from drug & device makers

$275in general payments, 2019–2025

Across 24 payments — averaging $11.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$159
  • Supernus Pharmaceuticals, Inc.$33
  • Pfizer$24
  • AbbVie$22
  • Bausch Health US, LLC$13
  • Sanofi Pasteur Inc.$13
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$26395%
  • Education$125%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$275 in reported general payments places this provider in the 40th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$79,353
Medicare patients
376
Services billed
2,473

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban142$141,260
JardianceEmpagliflozin71$87,921
OzempicSemaglutide53$56,770
XareltoRivaroxaban33$44,169
JanuviaSitagliptin Phosphate39$39,713
Lantus SolostarInsulin Glargine,hum.Rec.Anlog70$12,414
SymbicortBudesonide/Formoterol Fumarate33$9,388
CreonLipase/Protease/Amylase17$8,238
MyrbetriqMirabegron11$8,197
Rosuvastatin Calcium282$7,831
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen174$5,184
Colesevelam Hcl32$5,103
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate39$4,782
Gabapentin340$4,367
PaxlovidNirmatrelvir/Ritonavir22$4,271

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$24$145,531164 claims
AbbVieCreon, Synthroid$22$10,58654 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Dublin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →